271 related articles for article (PubMed ID: 16650911)
1. Role of stent design and coatings on restenosis and thrombosis.
Hara H; Nakamura M; Palmaz JC; Schwartz RS
Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
[TBL] [Abstract][Full Text] [Related]
2. A stent is not just a stent: Stent construction and design do matter in its clinical performance.
Lau KW; Johan A; Sigwart U; Hung JS
Singapore Med J; 2004 Jul; 45(7):305-11; quiz 312. PubMed ID: 15221045
[TBL] [Abstract][Full Text] [Related]
3. The influence of physical stent parameters upon restenosis.
Morton AC; Crossman D; Gunn J
Pathol Biol (Paris); 2004 May; 52(4):196-205. PubMed ID: 15145132
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents: a multidisciplinary success story.
Burt HM; Hunter WL
Adv Drug Deliv Rev; 2006 Jun; 58(3):350-7. PubMed ID: 16546288
[TBL] [Abstract][Full Text] [Related]
6. Passive stent coatings in the drug-eluting era.
Menown I; Lowe R; Penn I
J Invasive Cardiol; 2005 Apr; 17(4):222-8. PubMed ID: 15831978
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stents: role of stent design, delivery vehicle, and drug selection.
Rodgers CD
Rev Cardiovasc Med; 2002; 3 Suppl 5():S10-5. PubMed ID: 12478230
[TBL] [Abstract][Full Text] [Related]
9. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
10. Zotarolimus (ABT-578) eluting stents.
Burke SE; Kuntz RE; Schwartz LB
Adv Drug Deliv Rev; 2006 Jun; 58(3):437-46. PubMed ID: 16581153
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of drug-eluting stents: current best available evidence.
Raja SG; Dreyfus GD
J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
[TBL] [Abstract][Full Text] [Related]
13. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
Er F; Erdmann E
Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
[TBL] [Abstract][Full Text] [Related]
14. Stent design: implications for restenosis.
McLean DR; Eiger NL
Rev Cardiovasc Med; 2002; 3 Suppl 5():S16-22. PubMed ID: 12478231
[TBL] [Abstract][Full Text] [Related]
15. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
16. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
[TBL] [Abstract][Full Text] [Related]
17. Polymer coating techniques for drug-eluting stents.
al-Lamee K; Cook D
Med Device Technol; 2003; 14(1):12-4. PubMed ID: 12974119
[TBL] [Abstract][Full Text] [Related]
18. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
Pendyala L; Jabara R; Robinson K; Chronos N
J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
[TBL] [Abstract][Full Text] [Related]
19. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
20. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]